{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:56:56Z","timestamp":1772085416222,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100024161","name":"Universidade do Algarve","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100024161","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Public Health (Berl.)"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative disorder associated with a range of motor and non-motor symptom leading to progressive disability that significantly impacts on health related-quality of life (HRQoL) and imposes a substantial economic burden. The overall trend and impact of research production on the economic burden of PD have not yet been documented. In this study, the objective is to describe, map and analyse the evolution and trend of research on the economic burden in PD. Therefore, the initial research questions were: (1) what are the main research keywords on costs in the field of Parkinson\u2019s disease? and (2) how do an author\u2019s studies on the economic burden and costs of Parkinson\u2019s disease influence\u00a0scientific production?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The data used were retrieved from the Web of Science over the past 25\u00a0years, from 1997 to 2022. A bibliometric analysis was performed on the basis of the number of articles, citations, published journals, authors, countries scientific production and keywords plus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 140 articles that met the criteria were collected and analysed, covering 736 authors, 41 journals and 34 countries. The most productive country was the United States of America (80.71%) and, among the journals, the Movement Disorders journal was the one with the largest growth (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927). According to the thematic map, the terms \u201cquality of life\u201d, \u201cimpact\u201d and \u201cillness\u201d were considered as having a high level of centrality, a moderate density and a high frequency. In addition, the terms \u201cquality-of-life\u201d, \u201cimpact\u201d and illness were the most relevant words.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides an overview of global research trends on the economic burden of PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10389-024-02308-w","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T17:01:28Z","timestamp":1718470888000},"page":"597-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Economic burden of Parkinson\u2019s disease and research trends: a bibliometric analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Maura","family":"Cunha","sequence":"first","affiliation":[]},{"given":"Helena","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"given":"Lara N.","family":"Ferreira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"issue":"4","key":"2308_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/mdc3.12755","volume":"6","author":"N Afentou","year":"2019","unstructured":"Afentou N, Jarl J, Gerdtham UG, Saha S (2019) Economic evaluation of interventions in Parkinson\u2019s disease: a systematic literature review. Mov Disord Clin Pract 6(4):282\u2013290. https:\/\/doi.org\/10.1002\/mdc3.12755","journal-title":"Mov Disord Clin Pract"},{"issue":"4","key":"2308_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","volume":"11","author":"M Aria","year":"2017","unstructured":"Aria M, Cuccurullo C (2017) bibliometrix: an R-tool for comprehensive science mapping analysis. J Informet 11(4):959\u2013975. https:\/\/doi.org\/10.1016\/j.joi.2017.08.007","journal-title":"J Informet"},{"issue":"3","key":"2308_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11205-020-02281-3","volume":"149","author":"M Aria","year":"2020","unstructured":"Aria M, Misuraca M, Spano M (2020) Mapping the evolution of social research and data science on 30 years of social indicators research. Soc Indic Res 149(3):803\u2013831. https:\/\/doi.org\/10.1007\/s11205-020-02281-3","journal-title":"Soc Indic Res"},{"issue":"6","key":"2308_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"2308_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5932675","volume":"2017","author":"S Bohingamu Mudiyanselage","year":"2017","unstructured":"Bohingamu Mudiyanselage S, Watts JJ, Abimanyi-Ochom J, Lane L, Murphy AT, Morris ME, Iansek R (2017) Cost of living with Parkinson\u2019s disease over 12 months in australia: a prospective cohort study. Parkinson\u2019s Dis 2017:1\u201313. https:\/\/doi.org\/10.1155\/2017\/5932675","journal-title":"Parkinson\u2019s Dis"},{"key":"2308_CR6","doi-asserted-by":"publisher","unstructured":"Bovolenta TM, de Azevedo Silva SMC, Arb Saba R, Borges V, Ferraz HB, Felicio AC (2017) Systematic review and critical analysis of cost studies associated with Parkinson\u2019s disease. Parkinson\u2019s Dis 2017. https:\/\/doi.org\/10.1155\/2017\/3410946","DOI":"10.1155\/2017\/3410946"},{"key":"2308_CR7","first-page":"85","volume":"137","author":"SC Bradford","year":"1934","unstructured":"Bradford SC (1934) Sources of information on specific subjects. Engineering 137:85\u201386","journal-title":"Engineering"},{"key":"2308_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/224953a0","volume":"224","author":"BC Brookes","year":"1969","unstructured":"Brookes BC (1969) Bradford\u2019s law and the bibliography of science. Nature 224:953\u2013956","journal-title":"Nature"},{"key":"2308_CR9","doi-asserted-by":"publisher","unstructured":"Chen JW, Du SH, Chen TC, Zhu K (2022) Research hotspots and trends of exercise on Parkinson\u2019s disease: a global bibliometric analysis from 2012 to 2021. Front Hum Neurosci 16. https:\/\/doi.org\/10.3389\/fnhum.2022.908049","DOI":"10.3389\/fnhum.2022.908049"},{"issue":"6","key":"2308_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/asi.4630280610","volume":"28","author":"RC Coile","year":"1977","unstructured":"Coile RC (1977) Lotka\u2019s frequency distribution of scientific productivity. J Am Soc Inform Sci 28(6):366\u2013370. https:\/\/doi.org\/10.1002\/asi.4630280610","journal-title":"J Am Soc Inform Sci"},{"issue":"2","key":"2308_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/psyg.12196","volume":"17","author":"F Corallo","year":"2017","unstructured":"Corallo F, De Cola MC, Lo Buono V, Di Lorenzo G, Bramanti P, Marino S (2017) Observational study of quality of life of Parkinson\u2019s patients and their caregivers. Psychogeriatrics 17(2):97\u2013102. https:\/\/doi.org\/10.1111\/psyg.12196","journal-title":"Psychogeriatrics"},{"issue":"2","key":"2308_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11192-016-1948-8","volume":"108","author":"C Cuccurullo","year":"2016","unstructured":"Cuccurullo C, Aria M, Sarto F (2016) Foundations and trends in performance management. A twenty-five years bibliometric analysis in business and public administration domains. Scientometrics 108(2):595\u2013611. https:\/\/doi.org\/10.1007\/s11192-016-1948-8","journal-title":"Scientometrics"},{"issue":"6","key":"2308_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535. https:\/\/doi.org\/10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"issue":"2","key":"2308_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/ene.14584","volume":"28","author":"R Dodel","year":"2021","unstructured":"Dodel R, Tinelli M, Deuschl G, Petersen G, Oertel W, Ahmerkamp-B\u00f6hme J (2021) The economic benefit of timely, adequate, and adherence to Parkinson\u2019s disease treatment: the Value of Treatment Project 2. Eur J Neurol 28(2):707\u2013716. https:\/\/doi.org\/10.1111\/ene.14584","journal-title":"Eur J Neurol"},{"issue":"10","key":"2308_CR15","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/mds.10507","volume":"18","author":"L Findley","year":"2003","unstructured":"Findley L, Aujla M, Bain PG, Baker M, Beech C, Bowman C, Holmes J, Kingdom WK, MacMahon DG, Peto V, Playfer JR (2003) Direct economic impact of Parkinson\u2019s disease: a research survey in the United Kingdom. Mov Disord 18(10):1139\u20131145. https:\/\/doi.org\/10.1002\/mds.10507","journal-title":"Mov Disord"},{"issue":"7","key":"2308_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jamda.2016.03.004","volume":"17","author":"D Gr\u00fcn","year":"2016","unstructured":"Gr\u00fcn D, Pieri V, Vaillant M, Diederich NJ (2016) Contributory factors to caregiver burden in Parkinson disease. J Am Med Dir Assoc 17(7):626\u2013632. https:\/\/doi.org\/10.1016\/j.jamda.2016.03.004","journal-title":"J Am Med Dir Assoc"},{"issue":"11","key":"2308_CR17","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/mds.20609","volume":"20","author":"DM Huse","year":"2005","unstructured":"Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G (2005) Burden of illness in Parkinson\u2019s disease. Mov Disord 20(11):1449\u20131454. https:\/\/doi.org\/10.1002\/mds.20609","journal-title":"Mov Disord"},{"issue":"1","key":"2308_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12955-015-0281-x","volume":"13","author":"L Kadastik-Eerme","year":"2015","unstructured":"Kadastik-Eerme L, Rosenthal M, Paju T, Muldmaa M, Taba P (2015) Health-related quality of life in Parkinson\u2019s disease: a cross-sectional study focusing on non-motor symptoms. Health Qual Life Outcomes 13(1):83. https:\/\/doi.org\/10.1186\/s12955-015-0281-x","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"2308_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal SL, Dall TM, Chakrabarti R, Mv S, Jain A (2013) The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov Disord 28(3):311\u2013318. https:\/\/doi.org\/10.1002\/mds.25292","journal-title":"Mov Disord"},{"issue":"5","key":"2308_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40273-021-01011-y","volume":"39","author":"C Kruse","year":"2021","unstructured":"Kruse C, Kretschmer S, Lipinski A, Verheyen M, Mengel D, Balzer-Geldsetzer M, Lorenzl S, Richinger C, Schmotz C, T\u00f6nges L, Woitalla D, Klebe S, Schrag A, Dodel R (2021) Resource utilization of patients with Parkinson\u2019s disease in the late stages of the disease in Germany: data from the CLaSP study. Pharmacoeconomics 39(5):601\u2013615. https:\/\/doi.org\/10.1007\/s40273-021-01011-y","journal-title":"Pharmacoeconomics"},{"issue":"31","key":"2308_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029931","volume":"101","author":"Y Liu","year":"2022","unstructured":"Liu Y, Ding L, Xianyu Y, Nie S, Yang J (2022) Research on depression in Parkinson disease: a bibliometric and visual analysis of studies published during 2012\u20132021. Medicine 101(31):e29931. https:\/\/doi.org\/10.1097\/MD.0000000000029931","journal-title":"Medicine"},{"issue":"3","key":"2308_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14251","volume":"9","author":"W Liu","year":"2023","unstructured":"Liu W, Wu J, Zhang N, Chen G, Li J, Shen Y, Li F (2023) Postural deformities in Parkinson\u2019s disease: a bibliometric analysis based on web of science. Heliyon 9(3):e14251. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14251","journal-title":"Heliyon"},{"key":"2308_CR23","first-page":"317","volume":"16","author":"A Lotka","year":"1926","unstructured":"Lotka A (1926) The frequency distribution of scientific distribution. J Wash Acad Sci 16:317\u2013323","journal-title":"J Wash Acad Sci"},{"issue":"13","key":"2308_CR24","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/mds.23834","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, Selai C, Siderowf A, Welsh M, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG, Schrag A (2011a) Health-related quality-of-life scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 26(13):2371\u20132380. https:\/\/doi.org\/10.1002\/mds.23834","journal-title":"Mov Disord"},{"issue":"3","key":"2308_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR (2011b) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov Disord 26(3):399\u2013406. https:\/\/doi.org\/10.1002\/mds.23462","journal-title":"Mov Disord"},{"issue":"12","key":"2308_CR26","doi-asserted-by":"publisher","first-page":"e0145310","DOI":"10.1371\/journal.pone.0145310","volume":"10","author":"P Mart\u00ednez-Martin","year":"2015","unstructured":"Mart\u00ednez-Martin P, Rodriguez-Blazquez C, Paz S, Forjaz MJ, Frades-Payo B, Cubo E, de Pedro-Cuesta J, Liz\u00e1n L (2015) Parkinson symptoms and health related quality of life as predictors of costs: a longitudinal observational study with linear mixed model analysis. PLoS ONE 10(12):e0145310. https:\/\/doi.org\/10.1371\/journal.pone.0145310","journal-title":"PLoS ONE"},{"key":"2308_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H, Wang Z (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health 9:1. https:\/\/doi.org\/10.3389\/fpubh.2021.776847","journal-title":"Front Public Health"},{"issue":"5","key":"2308_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2017.e00300","volume":"3","author":"GS Patience","year":"2017","unstructured":"Patience GS, Patience CA, Blais B, Bertrand F (2017) Citation analysis of scientific categories. Heliyon 3(5):e00300. https:\/\/doi.org\/10.1016\/j.heliyon.2017.e00300","journal-title":"Heliyon"},{"key":"2308_CR29","unstructured":"Potter WG (1981) Lotka\u2019s Law Revisited"},{"issue":"11","key":"2308_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"E Ray Dorsey","year":"2018","unstructured":"Ray Dorsey E, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C, Choi JYJ, Collado-Mateo D, Dahodwala N, Do HP, Edessa D, Endres M, Fereshtehnejad SM, Foreman KJ, Gankpe FG, Gupta R, Hankey GJ, Murray CJL (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"2308_CR31","doi-asserted-by":"publisher","unstructured":"Reese JP, Winter Y, Rosa MM, Rodrigues e Silva AM, von Campenhausen S, Freire R, Mateus C, Balzer Geldsetzer M, B\u00f6tzel K, Oertel WH, Dodel R, Sampaio C (2011) Estudio de cohortes sobre la carga socioecon\u00f3mica de la enfermedad de Parkinson en Portugal. Rev Neurol 52(05):1\u201311. https:\/\/doi.org\/10.33588\/rn.5205.2010492","DOI":"10.33588\/rn.5205.2010492"},{"issue":"4","key":"2308_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/mdc3.13186","volume":"8","author":"K Rosqvist","year":"2021","unstructured":"Rosqvist K, Odin P, Lorenzl S, Meissner WG, Bloem BR, Ferreira JJ, Dodel R, Schrag A (2021) Factors associated with health-related quality of life in late-stage Parkinson\u2019s disease. Mov Disord Clin Pract 8(4):563\u2013570. https:\/\/doi.org\/10.1002\/mdc3.13186","journal-title":"Mov Disord Clin Pract"},{"issue":"11","key":"2308_CR33","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s11136-022-03187-y","volume":"31","author":"I Sanchez-Luengos","year":"2022","unstructured":"Sanchez-Luengos I, Lucas-Jim\u00e9nez O, Ojeda N, Pe\u00f1a J, G\u00f3mez-Esteban JC, G\u00f3mez-Beldarrain M\u00c1, V\u00e1zquez-Pic\u00f3n R, Foncea-Beti N, Ibarretxe-Bilbao N (2022) Predictors of health-related quality of life in Parkinson\u2019s disease: the impact of overlap between health-related quality of life and clinical measures. Qual Life Res 31(11):3241\u20133252. https:\/\/doi.org\/10.1007\/s11136-022-03187-y","journal-title":"Qual Life Res"},{"key":"2308_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neubiorev.2015.11.014","volume":"61","author":"JMT van Uem","year":"2016","unstructured":"van Uem JMT, Marinus J, Canning C, van Lummel R, Dodel R, Liepelt-Scarfone I, Berg D, Morris ME, Maetzler W (2016) Health-related quality of life in patients with Parkinson\u2019s disease-a systematic review based on the ICF model. Neurosci Biobehav Rev 61:26\u201334. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.11.014","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"2308_CR35","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/mds.27302","volume":"33","author":"S Weir","year":"2018","unstructured":"Weir S, Samnaliev M, Kuo TC, Tierney TS, Walleser Autiero S, Taylor RS, Schrag A (2018) Short- and long-term cost and utilization of health care resources in Parkinson\u2019s disease in the UK. Mov Disord 33(6):974\u2013981. https:\/\/doi.org\/10.1002\/mds.27302","journal-title":"Mov Disord"},{"issue":"1","key":"2308_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, Ray Dorsey E, Dahodwala N, Cintina I, Hogan P, Thompson T (2020) Current and projected future economic burden of Parkinson\u2019s disease in the U.S. Npj Parkinson\u2019s Dis 6(1):15. https:\/\/doi.org\/10.1038\/s41531-020-0117-1","journal-title":"Npj Parkinson\u2019s Dis"},{"issue":"4","key":"2308_CR37","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/asi.23437","volume":"67","author":"J Zhang","year":"2016","unstructured":"Zhang J, Yu Q, Zheng F, Long C, Lu Z, Duan Z (2016) Comparing keywords plus of WOS and author keywords: a case study of patient adherence research. J Am Soc Inf Sci 67(4):967\u2013972. https:\/\/doi.org\/10.1002\/asi.23437","journal-title":"J Am Soc Inf Sci"}],"container-title":["Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10389-024-02308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10389-024-02308-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10389-024-02308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:50:48Z","timestamp":1772077848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10389-024-02308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2308"],"URL":"https:\/\/doi.org\/10.1007\/s10389-024-02308-w","relation":{},"ISSN":["2198-1833","1613-2238"],"issn-type":[{"value":"2198-1833","type":"print"},{"value":"1613-2238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.This study was reviewed and approved by the Health Ethics Committee of the Algarve Local Health Unit [Comiss\u00e3o de \u00c9tica para a Sa\u00fade da Unidade Local de Sa\u00fade do Algarve] (references: 232\/22; 84\/23; 207.23).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}